Melanocyte-specific CD49a+CD8+ T cells in vitiligo lesion potentiate to maintain activity during systemic steroid therapy.
Melanocyte-specific CD49a+CD8+ T cells in vitiligo lesion potentiate to maintain activity during systemic steroid therapy.
复制标题
白癜风病变中黑素细胞特异性 CD49a CD8 T 细胞在全身类固醇治疗期间增强维持活性。
DOI:
10.1111/1346-8138.16680
复制
发表时间:
2023
影响因子:
3.1
通讯作者:
Tanemura A
中科院分区:
文献类型:
--
作者:
Yokoi K;Watanabe R;Kume M;Yamane S;Tanaka A;Fujimoto M;Tanemura A
Vitiligo is a common depigmenting skin disease that is often difficult to treat. Even if repigmentation is achieved by treatment, recurrence in the same lesion is often found within a year after stopping treatment. As a background of these issues, a subset of CD8+T cells that recognize melanocyte‐specific antigens or CD49a+tissue‐resident memory T cells that reside in the vitiligo lesion are thought to be involved. We investigated the MHC class I‐restricted tyrosinase pentamer‐positive CD8+skin T cells in a progressive generalized vitiligo patient with HLA‐A*02:01 who showed resistance to intravenous methylprednisolone pulse therapy. We found that HLA‐A*02:01‐restricted tyrosinase pentamer‐positive CD8+T cells remained in the lesions after the treatment and expressed IFN‐γ and granzyme B. Interestingly, the expression of these cytokines in the pentamer‐negative CD8+T cells was decreased after intravenous methylprednisolone pulse therapy. These findings suggest that, in vitiligo patients, melanocyte‐specific CD49a+CD8+T cells are in a potent activation state that is uncontrolled despite systemic immunosuppressive treatment, which may contribute to treatment resistance and local recurrence.